Form 4/A for ENTX Entera Bio Ltd.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-04-19 · accession 0001178913-24-002392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAI | 2024-08-02 | 2024-04-19 | ENTX | Yaacov-Garbeli Dana | CFO | A - Grant | $0.00 | +30.2K | 86.7K | +53% | $0 |
| DA | 2024-08-02 | 2024-04-19 | ENTX | Yaacov-Garbeli Dana | CFO | A - Grant | $0.00 | +130.0K | 130.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2024-04-19 | A | A | 30,151 | $0.00 | 86,731 | I By A2Z Counseling Ltd. | — | — | (F1) Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024. (F2) On April 23, 2024, the reporting person filed a Form 4 which inadvertently reported that the reporting person's ordinary shares and restricted stock units are held directly. (F3) These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| 2 | Derivative | Stock Option (right to buy) | 2024-04-19 | A | A | 130,000 | $0.00 | 130,000 | D | $1.99 · — to 2034-04-19 | 130,000 Ordinary Shares, par value NIS 0.0000769 per share | (F4) The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period. |